Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 40
Filtrer
1.
Cutis ; 110(4): 181-182, 2022 Oct.
Article de Anglais | MEDLINE | ID: mdl-36446106

RÉSUMÉ

Undermining in difficult-to-reach positions often requires a shift in body position or stretching over the surgical field to obtain adequate reach. We propose a technique of reversing the grip on undermining scissors that improves efficiency without sacrificing technique.


Sujet(s)
Procédures chirurgicales dermatologiques , Humains
3.
Dermatol Online J ; 28(6)2022 Dec 15.
Article de Anglais | MEDLINE | ID: mdl-36809099

RÉSUMÉ

Atypical fibroxanthoma is a rare cutaneous malignancy that usually presents as a rapidly growing red papule on the head and neck in elderly white males. Several variants have been described. We report a patient who presented with a slowly enlarging pigmented lesion on his left ear that was clinically worrisome for malignant melanoma. Histopathologic evaluation with immunohistochemistry revealed an unusual case of hemosiderotic pigmented atypical fibroxanthoma. The tumor was successfully extirpated with Mohs micrographic surgery, with no recurrence at 6-month follow-up.


Sujet(s)
Hémochromatose , Mélanome , Tumeurs cutanées , Mâle , Humains , Sujet âgé , Tumeurs cutanées/anatomopathologie , Mélanome/anatomopathologie , Immunohistochimie ,
9.
J Drugs Dermatol ; 20(3): 311-319, 2021 03 01.
Article de Anglais | MEDLINE | ID: mdl-33683082

RÉSUMÉ

As the incidence of non-melanoma skin cancer (NMSC) increases in the United States, one area of particular concern is NMSC arising on the genitalia. In the past, most genital skin tumors have been treated by conventional radical surgical approaches such as penectomy, vulvectomy, or wide local excision. In recent years, tissue sparing Mohs micrographic surgery (MMS) has been established as a safe and effective method of achieving cutaneous genital tumor clearance. The aim of this article is to provide an overview of NMSCs arising on genital skin treated with MMS, and describe some of their indications, results, and associated complications. A summary of case reports, case series, and retrospective reviews is made available to guide decision making and surgical planning for tumors of this nature. Pertinent anatomy, site-specific surgical techniques, and reconstruction options of genital skin will be discussed. J Drugs Dermatol. 2021;20(3):311-319. doi:10.36849/JDD.5656.


Sujet(s)
Tumeurs de l'appareil génital féminin/chirurgie , Tumeurs de l'appareil génital mâle/chirurgie , Chirurgie de Mohs/méthodes , Complications postopératoires/épidémiologie , Tumeurs cutanées/chirurgie , Carcinome basocellulaire/anatomopathologie , Carcinome basocellulaire/chirurgie , Carcinome épidermoïde/anatomopathologie , Carcinome épidermoïde/chirurgie , Femelle , Tumeurs de l'appareil génital féminin/anatomopathologie , Tumeurs de l'appareil génital mâle/anatomopathologie , Système génital/anatomopathologie , Système génital/chirurgie , Humains , Mâle , Chirurgie de Mohs/effets indésirables , Complications postopératoires/étiologie , Peau/anatomopathologie , Tumeurs cutanées/anatomopathologie , Résultat thérapeutique
10.
PLoS One ; 15(4): e0231639, 2020.
Article de Anglais | MEDLINE | ID: mdl-32324763

RÉSUMÉ

The anti-inflammatory cytokine interleukin-10 (IL10) is essential for attenuating inflammatory responses, which includes reducing the expression of pro-inflammatory microRNA-155 (miR155) in lipopolysaccharide (LPS) activated macrophages. miR155 enhances the expression of pro-inflammatory cytokines such as TNFα and suppresses expression of anti-inflammatory molecules such as SHIP1 and SOCS1. We previously found that IL10 interfered with the maturation of pre-miR155 to miR155. To understand the mechanism by which IL10 interferes with pre-miR155 maturation we isolated proteins that associate with pre-miR155 in response to IL10 in macrophages. We identified CELF2, a member of the CUGBP, ELAV-Like Family (CELF) family of RNA binding proteins, as protein whose association with pre-miR155 increased in IL10 treated cells. CRISPR-Cas9 mediated knockdown of CELF2 impaired IL10's ability to inhibit both miR155 expression and TNFα expression.


Sujet(s)
Protéines CELF/métabolisme , Interleukine-10/métabolisme , microARN/métabolisme , Précurseurs des ARN/métabolisme , Animaux , Cellules HEK293 , Humains , Lipopolysaccharides/pharmacologie , Souris , microARN/génétique , Oligonucléotides/métabolisme , Liaison aux protéines , Cellules RAW 264.7 , Précurseurs des ARN/génétique , Reproductibilité des résultats , Facteur de nécrose tumorale alpha/métabolisme
11.
Pediatr Dermatol ; 37(4): 748-749, 2020 Jul.
Article de Anglais | MEDLINE | ID: mdl-32173894

RÉSUMÉ

Verruca vulgaris is a common, benign infection of the skin and mucous membranes caused by human papillomavirus (HPV). Although many therapeutic options for warts exist, they have limited efficacy and there is no definitive cure for warts. We report the case of a 10-year-old girl with recalcitrant cutaneous warts persisting more than two years which resolved completely following vaccination with the nine-valent HPV vaccine.


Sujet(s)
Infections à papillomavirus , Vaccins contre les papillomavirus , Verrues , Enfant , Femelle , Humains , Papillomaviridae , Peau , Vaccination , Verrues/traitement médicamenteux
12.
J Psychiatr Pract ; 24(6): 428-431, 2018 Nov.
Article de Anglais | MEDLINE | ID: mdl-30395552

RÉSUMÉ

OBJECTIVE: Patients diagnosed with delusions of infestation (DOI) at a psychodermatology clinic appeared to have a higher incidence of being prescribed narcotic or stimulant medications compared with the general dermatologic clinic population with chronic pruritic conditions. A retrospective study was conducted examining the correlation between patients with DOI and prescribed psychoactive medications. METHODS: Ninety-two patients with a diagnosis of DOI, seen at our University Psychodermatology Clinic, served as the study population. The comparison group (N=354) included dermatology patients seen at a dermatology clinic by the same dermatologist for itching, including adults seen for chronic pruritic conditions and contact dermatitis. For both groups, the reported use of any psychoactive prescription medications was noted. RESULTS: Patients with DOI were significantly more likely than other dermatology patients to receive prescriptions for narcotics [adjusted odds ratio (OR)=2.19; confidence interval (CI)=1.21-3.99) and stimulants (OR=5.44; CI=2.37-12.52). Patients with DOI were also more likely to be female (OR=2.49; CI=1.47-4.22) than patients who did not have such delusions. DISCUSSION: Few data are available concerning the etiology and management of DOI. Findings from this study indicated an association between the diagnosis of DOI and the prescribing of narcotics and stimulants, even when sex and age were taken into account. This information may be used to assist with the diagnosis of patients presenting with DOI and possible treatment options. It will be important to determine if these medications are a cause of the condition, or are merely correlated with other medical conditions.


Sujet(s)
Stimulants du système nerveux central/effets indésirables , Parasitose délirante/induit chimiquement , Stupéfiants/effets indésirables , Adulte , Femelle , Humains , Mâle , Adulte d'âge moyen , Études rétrospectives , Maladies de la peau/traitement médicamenteux
13.
Dermatitis ; 29(3): 107-111, 2018.
Article de Anglais | MEDLINE | ID: mdl-29613858

RÉSUMÉ

Allergic contact dermatitis is associated with significant disease and economic burden in the United States. To properly manage allergic contact dermatitis, it is important to accurately identify the substance(s) implicated in the dermatitis to prevent disease recurrence. The commercially available T.R.U.E Test (36 allergens) screening panel has been reported to have a conservative hypothetical allergen detection rate of 66.0%, at most. Importantly, these calculations are based on the 78% of patients who had clinically relevant reactions to allergens present on the North American Contact Dermatitis Group screening series (70 allergens), without the use of supplemental allergens. Testing with supplemental allergens beyond a screening series can more fully evaluate an individual's environmental and occupational exposure, which may significantly increase diagnostic accuracy. Comprehensive patch testing with additional allergens in sunscreens, cosmetics, and fragrances, for example, may increase the diagnostic yield as well as the likelihood of achieving a cure if the dermatitis is chronic and recalcitrant.


Sujet(s)
Eczéma de contact allergique/diagnostic , Eczéma de contact allergique/étiologie , Tests épicutanés/méthodes , Humains
14.
Dermatitis ; 29(2): 85-88, 2018.
Article de Anglais | MEDLINE | ID: mdl-29494395

RÉSUMÉ

BACKGROUND: Allergic contact dermatitis (ACD) remains a significant burden of disease in the United States. Patch testing is the criterion standard for diagnosing ACD, but its use may be limited by reimbursement challenges. OBJECTIVE: This study aimed to assess the current rate of patch test utilization among dermatologists in academic, group, or private practice settings to understand different patch testing business models that address these reimbursement challenges. METHODS: All members of the American Contact Dermatitis Society received an online survey regarding their experiences with patch testing and reimbursement. RESULTS: A "yes" response was received from 28% of survey participants to the question, "Are you or have you been less inclined to administer patch tests or see patients needing patch tests due to challenges with receiving compensation for patch testing?" The most commonly reported barriers include inadequate insurance reimbursement and lack of departmental support. CONCLUSIONS: Compensation challenges to patch testing limit patient access to appropriate diagnosis and management of ACD. This can be addressed through a variety of innovative business models, including raising patch testing caps, negotiating relative value unit compensation, using a fixed salary model with directorship support from the hospital, and raising the percentages of collection reimbursement for physicians.


Sujet(s)
Eczéma de contact allergique/diagnostic , Eczéma de contact allergique/étiologie , Dermatologie/économie , Remboursement par l'assurance maladie , Tests épicutanés/économie , Tests épicutanés/statistiques et données numériques , Centres hospitaliers universitaires/économie , Dermatologie/organisation et administration , Dermatologie/statistiques et données numériques , Cabinets de groupe/économie , Cabinets de groupe/statistiques et données numériques , Humains , Modèles économiques , Services de consultations externes des hôpitaux/économie , Services de consultations externes des hôpitaux/statistiques et données numériques , Pratique professionnelle privée/économie , Pratique professionnelle privée/statistiques et données numériques , Échelles de valeur relative , Sociétés médicales , Enquêtes et questionnaires , Facteurs temps , États-Unis
19.
Dermatol Online J ; 23(5)2017 May 15.
Article de Anglais | MEDLINE | ID: mdl-28537861

RÉSUMÉ

Atopic dermatitis (AD) is a common inflammatory dermatosis characterized by pruritus, erythema, induration, and lichenification. Current treatment options for generalized atopic dermatitis are limited and have potentially serious adverse effects, especially in patients with severe, chronic AD who frequently require systemic anti-inflammatory agents. Apremilast, an oral phosphodiesterase-4 inhibitor, was FDA approved in September 2014 for the treatment of moderate-to-severe plaque psoriasis. However, its upstream anti-inflammatory effects, ease of use as an oral agent, and mild side-effect profile make it an interesting treatment option for AD as well. Herein, we present a patient with a life-long history of AD recalcitrant to topical steroids and cyclosporine who attained subjective and objective improvement in pruritus and erythema after 10-week treatment with apremilast.


Sujet(s)
Eczéma atopique/traitement médicamenteux , Produits dermatologiques/usage thérapeutique , Inhibiteurs de la phosphodiestérase-4/usage thérapeutique , Thalidomide/analogues et dérivés , Administration par voie orale , Maladie chronique , Humains , Mâle , Adulte d'âge moyen , Indice de gravité de la maladie , Thalidomide/usage thérapeutique
20.
J Transl Med ; 15(1): 73, 2017 04 08.
Article de Anglais | MEDLINE | ID: mdl-28388917

RÉSUMÉ

Recent studies have suggested that the intestinal microbiome plays an important role in modulating risk of several chronic diseases, including inflammatory bowel disease, obesity, type 2 diabetes, cardiovascular disease, and cancer. At the same time, it is now understood that diet plays a significant role in shaping the microbiome, with experiments showing that dietary alterations can induce large, temporary microbial shifts within 24 h. Given this association, there may be significant therapeutic utility in altering microbial composition through diet. This review systematically evaluates current data regarding the effects of several common dietary components on intestinal microbiota. We show that consumption of particular types of food produces predictable shifts in existing host bacterial genera. Furthermore, the identity of these bacteria affects host immune and metabolic parameters, with broad implications for human health. Familiarity with these associations will be of tremendous use to the practitioner as well as the patient.


Sujet(s)
Régime alimentaire , Microbiome gastro-intestinal , Santé , Humains , Polyphénols/pharmacologie , Probiotiques/pharmacologie
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...